Given this background with conflicting data, we tried to contribute with our survey to the growing body of evidence that anesthetic management may influence cancer recurrence in patients with radical prostatectomy due to prostate cancer. Methods After approval of the ethics committee, we checked our archives for patients who underwent radical retropubic prostatectomy between 01.01.1995 and 31.05.2005. Criteria for inclusion were: completely documented, standardized postoperative pain management either by intravenous patient-controlled analgesia with piritramide (i.v. pca; bolus: 1.5 mg, blocking period: 10 min, 4 h maximum: 30 mg) or by continuous epidural analgesia (EA; bupivacaine 0.06% with fentanyl 2 µg ml-1). All patients had the same anesthesiological treatment based on these institutional standard operation procedures. While obtaining written informed consent, the patients' postoperative pain regime-EA or systemic opioids-was defined. We excluded patients who underwent additional chemo-, radio